醛甾酮癥,醛甾酮增多癥,醛甾酮過多癥

Fifty-six consecutie patients who had primary aldosteronism and were recruited in a uniersity center were studied. 在一個大學(xué)中心研究了56名原發(fā)性醛固酮增多癥的患者。

Objective To investigate the value of i. v. saline load lest (SLT) in the diagnosis of primary aldosteronism (PA). 摘要目的探討靜脈鹽水負(fù)荷試驗在原發(fā)性醛固酮增多癥（原醛癥）診斷中的應(yīng)用價值。

There were 4 patients with primary aldosteronism,1 patient with nonfunctional adrenocortical adenoma,1 patient with primary adrenal nodular hyperplasia. 其中原發(fā)性醛固酮增多癥4例,無功能腺瘤1例,原發(fā)性腎上腺結(jié)節(jié)狀增生1例;

Endocrine hypertension comprised 59.70% of primary aldosteronism, 38.06% of pheochromocytoma, and there were 3 in-patients suffered from cushing syndrome. 在內(nèi)分泌性高血壓中，原發(fā)性醛固酮增多癥占59.

Objective To study the clinical value of 18-hydroxycortisol assay in the differential diagnosis of primary aldosteronism. 目的探討18-羥皮質(zhì)醇在原發(fā)性醛固酮增多癥(原醛)鑒別診斷中的應(yīng)用價值。

MRAs treat a condition called primary aldosteronism, which is found in about 20% of patients with resistant hypertension. MRAs可以治療原發(fā)性醛固酮增高癥（原醛），研究發(fā)現(xiàn)20%25的頑固性高血壓患者合并有原醛。